 development tumors mice receptor transfectant tumor cells number different immunotherapeutic reagents treatment leukemia graft rejection certain autoimmune diseases chimeric protein human N-terminus truncated form Pseudomonas exotoxin PE variety cell lines vitro low intermediate high affinity growth lethal tumor solid tumor murine thymoma cells murine transfected line high affinity Survival extension ascites model treatment days post-tumor injection athymic nude mice growth aggressive solid tumor Extension survival truncated toxin mutant functional toxin Survival extension NK host effector unable receptor-negative parental line lethal ascites solid tumor potent specific cytolytic reagent useful arsenal immunotherapeutics